Showing results (2311-2320 of 6,161) with videos related to
Sort By:
Pageof 617
Nature Medicine|October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trialJing Pan, Yue Tan, Lingling Shan, et al.Nature Medicine|October 1, 2024
Increased frequency of repeat expansion mutations across different populationsKristina Ibañez, Bharati Jadhav, Matteo Zanovello, et al.Nature Medicine|October 1, 2024
Sacituzumab govitecan in HR+HER2- metastatic breast cancer: the randomized phase 3 EVER-132-002 trialBinghe Xu, Shusen Wang, Min Yan, et al.Nature Medicine|September 20, 2024
High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Tobias Weiss, Marcel Bühler, et al.Nature Medicine|September 20, 2024
Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesityYun Huang, Karolina Sulek, Sara E Stinson, et al.Nature Medicine|September 23, 2024
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trialScott Kopetz, Danielle A Murphy, Jie Pu, et al.Nature Medicine|September 18, 2024
Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon regionFelipe Gomes Naveca, Tatiana Amaral Pires de Almeida, Victor Souza, et al.Nature Medicine|September 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trialIris Nederlof, Olga I Isaeva, Manon de Graaf, et al.Nature Medicine|October 25, 2024
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trialEllen M Apperloo, Jose L Gorriz, Maria Jose Soler, et al.Nature Medicine|February 28, 2025
Rapid brain tumor classification from sparse epigenomic dataBjörn Brändl, Mara Steiger, Carolin Kubelt, et al.Pageof 617